Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine

Drug Metabolism and Disposition

Volumn 28, Issue 9, 2000, Pages 1043-1050

  Ngui, Jason S ^a   Tang, W E I ^a   Stearns, Ralph A ^a   Shou, Magang ^a   Miller, Randall R ^a   Zhang, Yong ^a   Lin, Jiunn H ^a   Baillie, Thomas A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; QUINIDINE; RECOMBINANT ENZYME;

ARTICLE; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KINETICS; LIVER CELL; LIVER METABOLISM; LIVER MICROSOME; MICROSOME; PRIORITY JOURNAL;

CYTOCHROME C GROUP; CYTOCHROME P-450 ENZYME SYSTEM; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; KINETICS; LIVER; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; OXIDATION-REDUCTION; OXIDOREDUCTASES; QUINIDINE; RECOMBINANT PROTEINS;

EID: 0033831233     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the Food and Drug Administration as adverse reactions
2. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: Molecular mechanisms and pathology
3. Fatal hepatitis associated with diclofenac
4. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids
5. Dual role of human cytochrome P450 3A4 residue PHE-304 in substrate specificity and cooperativity
6. Role of cytochrome P450 enzymes in drug-drug interactions
7. Isolation, characterization and synthesis of a new quinidine metabolite
8. Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac
9. Analysis of human cytochrome P450 3A4 cooperativity: Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics
10. Diclofenac-associated hepatotoxicity
11. Human liver carbamazepine metabolism: Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation
12. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites
13. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins: Retention of the glucuronic acid moiety in the adduct
14. Inhibition and activation of acetaminophen reactive metabolite formation by caffeine: Role of cytochromes P450IA1 and IIIA2
15. Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver
16. An algorithm for least-squares estimation of nonlinear parameters
17. Role of a potent inhibitory monoclonal antibody to cytochrome P450 3A4 in assessment of human drug metabolism
18. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
19. Toxicity of allyl alcohol in primary cultures of freshly isolated and cryopreserved hepatocytes maintained on hydrated collagen gels
20. Diclofenac hepatitis
21. Isolation of P450 enzymes from human liver
22. Metabolic activation of diclofenac by human cytochrome P450 3A4: Role of 5-hydroxydiclofenac
23. Activation of CYP3A4: Evidence for the simultaneous binding of two substrates in a cytochrome P450 active site
24. Molecular basis of P450 inhibition and activation: Implications for drug development and drug therapy
25. Biotransformation of diclofenac sodium (Voltaren) in animals and in man, I: Isolation and identification of principal metabolites
26. Biotransformation of diclofenac sodium (Voltaren) in animals and in man, II: Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile
27. Studies on hepatic cytochrome P450-mediated bioactivation of diclofenac in rats and in human hepatocytes: Identification of glutathione conjugated metabolites
28. Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism
29. Roles of human hepatic cytochrome P450 2C9 and 3A4 in the metabolic activation of diclofenac
30. Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymes
31. Cooperativity in oxidations catalyzed by cytochrome P450 3A4
32. The extinction coefficient of cytochrome c